We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
-16.78%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$25.5B
AUM Growth
-$11.1B
(-30%)
Cap. Flow
-$5.25B
Cap. Flow
% of AUM
-20.57%
Top 10 Holdings %
Top 10 Hldgs %
6.83%
Holding
3,851
New
730
Increased
952
Reduced
1,216
Closed
943
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$230M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$207M |
| 3 |
Electronic Arts
EA
|
+$205M |
| 4 |
Starbucks
SBUX
|
+$171M |
| 5 |
Baidu
BIDU
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$185M |
| 2 |
Elevance Health
ELV
|
+$180M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$169M |
| 4 |
Walt Disney
DIS
|
+$168M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.44% |
| 2 | Technology | 14.21% |
| 3 | Industrials | 12.1% |
| 4 | Healthcare | 9.72% |
| 5 | Financials | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLCM
2051
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $542K | ﹤0.01% |
18,548
+17,187
| +1,263% | +$762K |
|
|
IMDZ
2052
DELISTED
Immune Design Corp.
IMDZ
| $540K | ﹤0.01% |
415,254
+274,335
| +195% | +$477K |
|
|
BFIN
2053
DELISTED
BankFinancial
BFIN
| $537K | ﹤0.01% |
35,932
-6,021
| -14% | -$88.8K |
|
|
WBC
2054
CALL
DELISTED
WABCO HOLDINGS INC.
WBC
| $537K | ﹤0.01% |
5,000
+3,200
| +178% | +$354K |
|
2055
CALL
Snap
SNAP
$8.83B
| $536K | ﹤0.01% |
+97,200
| New | +$632K |
|
2056
CALL
General Motors
GM
$76.3B
| $535K | ﹤0.01% |
16,000
-77,400
| -83% | -$2.67M |
|
|
AGN
2057
PUT
DELISTED
Allergan plc
AGN
| $535K | ﹤0.01% |
4,000
| – | – |
|
2058
PUT
Edison International
EIX
$25.9B
| $534K | ﹤0.01% |
9,400
-2,600
| -22% | -$162K |
|
2059
CALL
Cheniere Energy
LNG
$55.7B
| $533K | ﹤0.01% |
9,000
+5,000
| +125% | +$308K |
|
2060
Cartesian Therapeutics
RNAC
$257M
| $533K | ﹤0.01% |
6,683
+3,124
| +88% | +$713K |
|
2061
Renasant Corp
RNST
$3.96B
| $533K | ﹤0.01% |
+17,660
| New | +$619K |
|
2062
CALL
Roper Technologies
ROP
$39.3B
| $533K | ﹤0.01% |
2,000
-2,800
| -58% | -$792K |
|
|
ZEN
2063
PUT
DELISTED
ZENDESK INC
ZEN
| $531K | ﹤0.01% |
+9,100
| New | +$524K |
|
2064
Evolus
EOLS
$488M
| $530K | ﹤0.01% |
+44,577
| New | +$636K |
|
2065
First Interstate BancSystem
FIBK
$3.57B
| $527K | ﹤0.01% |
14,407
+4,100
| +40% | +$170K |
|
|
2066
PUT
Elevance Health
ELV
$84.9B
| $525K | ﹤0.01% |
+2,000
| New | +$550K |
|
2067
Nu Skin
NUS
$252M
| $524K | ﹤0.01% |
8,551
-55,796
| -87% | -$3.76M |
|
|
EXTN
2068
DELISTED
Exterran Corporation
EXTN
| $524K | ﹤0.01% |
+29,596
| New | +$664K |
|
2069
CALL
AvalonBay Communities
AVB
$26.6B
| $522K | ﹤0.01% |
3,000
-7,200
| -71% | -$1.3M |
|
|
PDM
2070
Piedmont Realty Trust
PDM
$1.18B
| $522K | ﹤0.01% |
+30,663
| New | +$558K |
|
2071
CALL
Prudential Financial
PRU
$41.9B
| $522K | ﹤0.01% |
6,400
-7,100
| -53% | -$654K |
|
2072
PUT
Terex
TEX
$7.47B
| $521K | ﹤0.01% |
18,900
+900
| +5% | +$28.8K |
|
|
CNCE
2073
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $521K | ﹤0.01% |
41,539
-29,367
| -41% | -$405K |
|
2074
Willdan Group
WLDN
$1.11B
| $520K | ﹤0.01% |
14,879
-9,053
| -38% | -$310K |
|
2075
CALL
Zimmer Biomet
ZBH
$18.8B
| $519K | ﹤0.01% |
+5,150
| New | +$579K |
|
Similar funds
VAM
Two Sigma Investments's Q4 2018 Portfolio in Review
As of Q4 2018, Two Sigma Investments held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Two Sigma Investments withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, Two Sigma Investments opened a new position in Starbucks worth $176M.
- Two Sigma Investments's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
- Two Sigma Investments added most to SLB Ltd in Q4 2018, an estimated $230M increase.
- Two Sigma Investments's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
- Two Sigma Investments fully exited Elevance Health in Q4 2018, selling an estimated $180M.
- Two Sigma Investments's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
- Two Sigma Investments opened 730 new positions and closed 943 in Q4 2018.
- Two Sigma Investments's portfolio value fell 30% quarter-over-quarter to $25.5B.
Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.